- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Hong Kong Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
67
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
67 companies
CARsgen Therapeutics Holdings
Market Cap: HK$6.7b
An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United States.
2171
HK$12.82
7D
17.8%
1Y
169.3%
3SBio
Market Cap: HK$29.2b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$12.86
7D
27.1%
1Y
118.7%
China Traditional Chinese Medicine Holdings
Market Cap: HK$9.7b
China Traditional Chinese Medicine Holdings Co.
570
HK$1.95
7D
8.9%
1Y
-54.9%
JBM (Healthcare)
Market Cap: HK$1.6b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.07
7D
36.2%
1Y
125.0%
YiChang HEC ChangJiang Pharmaceutical
Market Cap: HK$9.2b
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
1558
HK$11.50
7D
31.0%
1Y
-9.6%
Sino Biopharmaceutical
Market Cap: HK$64.1b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$3.74
7D
12.0%
1Y
39.6%
Consun Pharmaceutical Group
Market Cap: HK$7.8b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.76
7D
15.9%
1Y
72.4%
Modern Chinese Medicine Group
Market Cap: HK$213.0m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.35
7D
44.9%
1Y
10.9%
Shandong Xinhua Pharmaceutical
Market Cap: HK$8.3b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$5.50
7D
6.0%
1Y
2.6%
Essex Bio-Technology
Market Cap: HK$2.6b
An investment holding company, develops, manufactures, and sells biologic drugs in the People’s Republic of China, Hong Kong, and internationally.
1061
HK$4.59
7D
10.6%
1Y
104.0%
WuXi Biologics (Cayman)
Market Cap: HK$81.7b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$21.20
7D
16.0%
1Y
56.1%
Abbisko Cayman
Market Cap: HK$4.3b
Engages in the discovering and developing small molecule oncology therapies in China.
2256
HK$7.20
7D
16.3%
1Y
137.6%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$382.5m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.34
7D
-5.6%
1Y
38.8%
China Shineway Pharmaceutical Group
Market Cap: HK$5.7b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong.
2877
HK$7.76
7D
6.0%
1Y
-17.3%
China Health Group
Market Cap: HK$141.3m
An investment holding company, provides research and development services of drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.
8225
HK$0.14
7D
-10.0%
1Y
33.3%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.14
7D
2.7%
1Y
-3.4%
United Laboratories International Holdings
Market Cap: HK$22.7b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$13.32
7D
18.5%
1Y
35.6%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
Market Cap: HK$6.5b
Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.
1349
HK$2.39
7D
11.7%
1Y
14.9%
Simcere Pharmaceutical Group
Market Cap: HK$20.1b
Engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China.
2096
HK$8.17
7D
11.9%
1Y
56.2%
China Medical System Holdings
Market Cap: HK$17.5b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$7.53
7D
5.3%
1Y
5.3%
Pak Fah Yeow International
Market Cap: HK$707.4m
An investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.28
7D
7.0%
1Y
11.2%
Jacobson Pharma
Market Cap: HK$2.5b
Through its subsidiaries, develops, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.27
7D
16.5%
1Y
122.8%
Lee's Pharmaceutical Holdings
Market Cap: HK$718.4m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.
950
HK$1.30
7D
4.0%
1Y
12.1%
HBM Holdings
Market Cap: HK$5.2b
A clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas.
2142
HK$7.77
7D
43.1%
1Y
569.8%
Qyuns Therapeutics
Market Cap: HK$1.8b
A clinical-stage biotech company, focuses on the research and development of biologic therapies for autoimmune and allergic diseases in the People’s Republic of China.
2509
HK$8.30
7D
5.1%
1Y
-63.7%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$68.6b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs to address unmet medical needs in the People’s Republic of China and internationally.
6990
HK$321.00
7D
32.6%
1Y
127.7%
Shanghai Junshi Biosciences
Market Cap: HK$26.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$15.18
7D
19.7%
1Y
47.4%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$941.2m
Engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$1.69
7D
9.0%
1Y
-6.6%
Hansoh Pharmaceutical Group
Market Cap: HK$134.1b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$22.80
7D
10.4%
1Y
40.7%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.1b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.54
7D
4.3%
1Y
-5.6%
VISEN Pharmaceuticals
Market Cap: HK$4.8b
A biopharmaceutical company, engages in the research, development, and commercialization of paradigm-shifting endocrine therapies in Hong Kong, Macau, Taiwan, and rest of China.
2561
HK$42.50
7D
4.2%
1Y
n/a
SSY Group
Market Cap: HK$9.0b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.06
7D
3.0%
1Y
-36.3%
Hangzhou Jiuyuan Genetic Biopharmaceutical
Market Cap: HK$1.4b
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
2566
HK$6.05
7D
8.2%
1Y
n/a
CSPC Pharmaceutical Group
Market Cap: HK$60.5b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally.
1093
HK$5.77
7D
21.7%
1Y
-1.7%
Everest Medicines
Market Cap: HK$15.7b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$50.25
7D
11.4%
1Y
111.1%
Uni-Bio Science Group
Market Cap: HK$400.1m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.069
7D
13.1%
1Y
-19.8%